B302-05

Bovine Pulmonary Artery Endothelial Cells: BPAEC (Cryovial)

Manufacturer: Sigma Aldrich

Select a Size

Pack Size SKU Availability Price
1 EACH B302-05-1-EACH In Stock ₹ 84,304.50

B302-05 - 1 EACH

₹ 84,304.50

In Stock

Quantity

1

Base Price: ₹ 84,304.50

GST (18%): ₹ 15,174.81

Total Price: ₹ 99,479.31

biological source

bovine pulmonary artery (USDA-inspected cattle)

packaging

pkg of 500,000 cells

manufacturer/tradename

Cell Applications, Inc

growth mode

Adherent

karyotype

2n = 60

morphology

Endothelial

technique(s)

cell culture | mammalian: suitable

relevant disease(s)

diabetes; cardiovascular diseases

storage temp.

−196°C

Related Products

Img

Sigma Aldrich

B300-05

--

Img

Sigma Aldrich

B304-05

--

Img

Sigma Aldrich

B354-05

--

Img

Sigma Aldrich

CN304-05

--

Img

Sigma Aldrich

R304-05A

--

Img

Sigma Aldrich

302-05A

--

Img

Sigma Aldrich

B352-05

--

Img

Sigma Aldrich

P302-05

--

Description

  • General description: Lot specific orders are not able to be placed through the web. Contact your local sales rep for more details. Bovine large artery endothelial cells (BPAEC) provide an excellent model system to study many aspects of cardiovascular function and disease, for example to investigate critical signaling pathways and mechanisms relevant to proper endothelial function, such as angiogenesis, permeability, NO production, etc., and search for beneficial modulators for therapeutic use, study diabetes-associated complications related to cardiovascular function, investigate mechanisms of endothelial dysfunction related to environmental pollution, smoking, oxidative stress and inflammation and search for potential treatments, and develop layered co-cultures of liver and endothelial cells that demonstrate superior liver-specific features.BPAEC have been utilized in multiple research publications, for example to:Determine that induction of cellular antioxidant glutathione during moderate oxidative stress involves ARE-binding factors in a MAP kinase independent mechanism (Day, 2003)Show that HGF transiently increases transcription of angiotensin-converting enzyme gene via activation of Egr-1, whereas PMA regulation involves Egr-1 and additional factors (Day, 2004)Elucidate the therapeutic effects of Angiotensin I-converting enzyme (ACE) inhibitors, and the results revealed that they provide an additional benefit to patients by activating bradykinin B1 receptor leading to prolonged nitric oxide (NO) production in endothelial cells (Ignjatovic, 2004)Demonstrate that thiol-reactive compounds in cigarette smoke activate NADPH oxidase and increase superoxide anion production, reducing NO levels and resulting in endothelial dysfunction (Jaimes, 2004)Reveal that mercury, a risk factor for cardiovascular diseases, induces PLA2 activation in endothelial cells, followed by PLD activation, and the process is mediated by thiol-redox alteration, ROS and Ca2+/calmodulin (Hagele, 2006, 2007; Mazerik, 2007; Peltz, 2009; Sherwani, 2013)Demonstrate that adiponectin protects against the hyperoxia-induced endothelial barrier dysfunction and lung damage by relieving oxidative stress and normalizing thiol-redox status (Sliman, 2013)Show that TGF-β1–induced endothelial permeability involves focal adhesion and cytoskeletal rearrangement through both FAK/Src-dependent and -independent pathways (Lee, 2007)Demonstrate that exposure to lipopolysaccharides inhibits AMPK (which is required for normal endothelial barrier function) and causes endothelial hyperpermeability and lung injury (Xing, 2013)Demonstrate the effectiveness of myosin light chain kinase inhibitors in decreasing endothelial hyperpermeability (Marchenko, 2010)Show that angiotensin II-induced apoptosis relies on activation of AMPK for ATP production, as well as for activation of SHP-2 in a signaling cascade leading to Bcl-x(L) mRNA destabilization (Day, 2011)Evaluate therapeutic potential of aminoguanidine in protecting endothelia from hyperglycemic complications in diabetes by blocking the reactivity of the sugar-derived dicarbonyls and preventing the formation of advanced glycation end products (Sliman, 2010)Demonstrate the roles of Egr-1, ATF-2 and Ets-1 in the regulation of angiotensin converting enzyme promoter by phorbol ester (Mungunsukh, 2008)Develop a therapeutic peptide based on a fragment of Listeria monocytogenes internalin B that prevented angiotensin II-induced apoptosis and stimulated proliferation and cell motility by activating ERK1/2, STAT3, and phosphatidylinositol 3-kinase/Akt pathways (Mungunsukh, 2010)Develop layered co-cultures of liver and endothelial cells that demonstrate superior liver-specific features (Ohno, 2008, 2009a, b)
  • Cell Line Origin: Artery
  • Application: cardiovascular function, screening of drug candidates, angiogenesis, vasodilator function, transport of deoxygenated bloood from heart to lungs
  • Components: Bovine Endothelial Cell Growth Medium containing 10% FBS & 10% DMSO
  • Preparation Note: 2nd passage, >500,000 cells in Bovine Endothelial Cell Growth Medium containing 10% FBS & 10% DMSOCan be cultured at least 16 doublings
  • Subculture Routine: Please refer to the BPAEC Culture Protocol.

SAFETY INFORMATION

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Compare Similar Items

Show Difference

Img

Sigma Aldrich

B302-05

--


biological source:
bovine pulmonary artery (USDA-inspected cattle)

packaging:
pkg of 500,000 cells

manufacturer/tradename:
Cell Applications, Inc

growth mode:
Adherent

karyotype:
2n = 60

morphology:
Endothelial

technique(s):
cell culture | mammalian: suitable

relevant disease(s):
diabetes; cardiovascular diseases

storage temp.:
−196°C

Img

Supelco

B3022

analytical standard, for drug analy...


biological source:
__

packaging:
__

manufacturer/tradename:
__

growth mode:
__

karyotype:
__

morphology:
__

technique(s):
HPLC: suitablegas chromatography (GC): suitable

relevant disease(s):
__

storage temp.:
2-8°C

Img

TCI America

B3022-5G

--


biological source:
__

packaging:
__

manufacturer/tradename:
__

growth mode:
__

karyotype:
__

morphology:
__

technique(s):
__

relevant disease(s):
__

storage temp.:
__

Img

Sigma Aldrich

B304-05

--


biological source:
bovine aorta (USDA-inspected cattle)

packaging:
pkg of 500,000 cells

manufacturer/tradename:
Cell Applications, Inc

growth mode:
Adherent

karyotype:
2n = 60

morphology:
Endothelial

technique(s):
cell culture | mammalian: suitable

relevant disease(s):
diabetes; cardiovascular diseases

storage temp.:
__